Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis

Background and purpose: Activation of liver X receptor (LXR) by its ligand T0901317 (T317) enhances interferon-γ (IFNγ) production to inhibit tumor growth. However, induction of severe hypertriglyceridemia and fatty liver by T317 limits its application. The naphthylacetic acid modified D-enantiomeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ke, Ma, Chuanrui, Liu, Yuxin, Yang, Xiaoxiao, Yang, Zhimou, Chen, Yaoxia, Xu, Tengyan, Yang, Chengbiao, Zhang, Shuang, Li, Qi, Wei, Zhuo, Zhao, Dan, Zeng, Peng, Han, Jihong, Gao, Jie, Chen, Yuanli, Duan, Yajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806465/
https://www.ncbi.nlm.nih.gov/pubmed/33456564
http://dx.doi.org/10.7150/thno.53139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806465/
https://www.ncbi.nlm.nih.gov/pubmed/33456564
http://dx.doi.org/10.7150/thno.53139

Ejemplares similares